Tropical spastic paraplegia
ICD-10 G04.1 is a billable code used to indicate a diagnosis of tropical spastic paraplegia.
Tropical spastic paraplegia, also known as tropical spastic paraparesis, is a neurological condition primarily caused by infection with the human T-lymphotropic virus type I (HTLV-I). This condition is characterized by progressive weakness and stiffness of the legs, leading to spasticity and gait disturbances. Patients may also experience sensory disturbances, bladder dysfunction, and in some cases, cognitive impairment. The onset of symptoms typically occurs years after the initial viral infection, making diagnosis challenging. The condition is endemic in certain tropical regions, particularly in parts of Africa, South America, and the Caribbean. Diagnosis is often confirmed through serological testing for HTLV-I antibodies, and MRI may reveal changes in the spinal cord. Management focuses on symptomatic relief, including physical therapy and medications to reduce spasticity. Understanding the epidemiology and clinical manifestations of tropical spastic paraplegia is crucial for healthcare providers in endemic areas, as early recognition can significantly impact patient quality of life.
Detailed clinical notes on neurological examination findings, serological test results, and treatment plans.
Patients presenting with progressive leg weakness, spasticity, and sensory changes.
Ensure thorough documentation of the patient's history, including potential exposure to HTLV-I.
Documentation of viral testing, patient history regarding endemic exposure, and treatment protocols.
Patients with confirmed HTLV-I infection presenting with neurological symptoms.
Highlight the importance of distinguishing between HTLV-I related conditions and other infectious causes.
Used in conjunction with G04.1 for assessing cognitive function in patients.
Document the purpose of testing and results.
Neurologists should ensure comprehensive cognitive assessments are included.
The primary cause of tropical spastic paraplegia is infection with the human T-lymphotropic virus type I (HTLV-I), which leads to neurological complications.
